- Home
- PYPD vs TURN Comparison
PYPD vs TURN Comparison
Compare PYPD & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- TURN
- Stock Information
- Founded
- PYPD 2008
- TURN 1981
- Country
- PYPD Israel
- TURN United States
- Employees
- PYPD N/A
- TURN N/A
- Industry
- PYPD Medical/Dental Instruments
- TURN Finance/Investors Services
- Sector
- PYPD Health Care
- TURN Finance
- Exchange
- PYPD Nasdaq
- TURN Nasdaq
- Market Cap
- PYPD 35.3M
- TURN 39.9M
- IPO Year
- PYPD 2020
- TURN N/A
- Fundamental
- Price
- PYPD $3.44
- TURN $4.00
- Analyst Decision
- PYPD Strong Buy
- TURN
- Analyst Count
- PYPD 5
- TURN 0
- Target Price
- PYPD $11.40
- TURN N/A
- AVG Volume (30 Days)
- PYPD 1.4M
- TURN 20.2K
- Earning Date
- PYPD 08-13-2025
- TURN 01-01-0001
- Dividend Yield
- PYPD N/A
- TURN N/A
- EPS Growth
- PYPD N/A
- TURN N/A
- EPS
- PYPD N/A
- TURN N/A
- Revenue
- PYPD N/A
- TURN $194,813.00
- Revenue This Year
- PYPD N/A
- TURN N/A
- Revenue Next Year
- PYPD N/A
- TURN N/A
- P/E Ratio
- PYPD N/A
- TURN N/A
- Revenue Growth
- PYPD N/A
- TURN 254.25
- 52 Week Low
- PYPD $2.30
- TURN $3.12
- 52 Week High
- PYPD $4.49
- TURN $4.25
- Technical
- Relative Strength Index (RSI)
- PYPD 56.85
- TURN 51.32
- Support Level
- PYPD $3.45
- TURN $3.93
- Resistance Level
- PYPD $3.62
- TURN $4.01
- Average True Range (ATR)
- PYPD 0.20
- TURN 0.06
- MACD
- PYPD -0.01
- TURN 0.00
- Stochastic Oscillator
- PYPD 63.57
- TURN 77.25
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.